arctigenin has been researched along with Acute Lung Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shan, L; Shi, X; Sun, H; Xi, H; Zhou, D | 1 |
He, BX; Jiang, ZK; Liu, XB; Zhang, WZ | 1 |
2 other study(ies) available for arctigenin and Acute Lung Injury
Article | Year |
---|---|
Arctigenin attenuates lipopolysaccharide-induced acute lung injury in rats.
Topics: Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Down-Regulation; Enzyme Activation; Furans; I-kappa B Proteins; Interleukin-1beta; Interleukin-6; Lignans; Lipopolysaccharides; Lung; Male; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Peroxidase; Phosphorylation; Random Allocation; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |
Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Furans; Heme Oxygenase-1; Lignans; Lipopolysaccharides; Male; MAP Kinase Signaling System; Membrane Proteins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Oxidative Stress; Protective Agents | 2015 |